Bio-Techne Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Bio-Techne Corporation (TECH) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021
Operating Activities
Net Income73.40168.11285.44272.05140.41
Depreciation & Amortization109.90111.7162.94101.0751.25
Deferred Income Tax-51.11-39.45-29.576.820.00
Stock Based Compensation40.8338.0439.2342.1848.98
Change in Working Capital11.54-10.11-90.58-69.5229.26
Change in Accounts Receivable42.60-20.53-20.87-57.60-15.55
Change in Inventory-18.14-14.22-30.17-32.01-7.14
Change in Accounts Payable-13.9525.77-7.9115.4119.09
Change in Other Working Capital1.04-0.76-29.14-22.6419.44
Other Operating Activities102.99-0.76-39.23-22.64-22.12
Net Cash from Operating Activities287.56298.98254.39325.27352.16
Investing Activities
Capital Expenditures-31.01-62.88-38.24-44.91-44.30
Acquisitions-15.00-169.71-101.180.00-225.35
Purchases of Investments0.00-5.53-144.05-78.0026.14
Sales/Maturities of Investments1.0928.08108.4626.060.00
Other Investing Activities9.740.000.00-25.000.00
Net Cash from Investing Activities-35.18-203.03-265.65-96.85-243.52
Financing Activities
Debt Repayment27.00-256.00-525.66-175.500.00
Common Stock Issued0.0060.9429.8177.1665.09
Common Stock Repurchased-275.73-80.04-48.46-160.95-62.52
Dividends Paid-50.39-50.42-50.29-50.19-49.62
Other Financing Activities45.22-21.87-2.46-23.370.00
Net Cash from Financing Activities-253.91-122.4022.62-242.85-62.55
Summary
Effect of Forex Changes on Cash11.93-2.33-3.36-12.090.00
Net Change in Cash10.40-26.458.00-14.4352.47
Cash at Beginning of Period151.79180.57172.57199.090.00
Cash at End of Period162.19151.79180.57172.570.00
Free Cash Flow256.55236.10216.15280.36307.86
Supplemental Disclosures
Interest Paid18.9614.508.3711.0313.58
Income Taxes Paid74.3665.2588.4330.3420.95